Robertson Stephens Wealth Management’s Immunocore IMCR Stock Holding History

Robertson Stephens Wealth Management’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,030	Closed	-$209K	–	640
2025 Q4	$209K	Hold	6,030	–	–	0.01%	598
2025 Q3	$219K	Buy	+6,030	New	+$205K	0.01%	501
2025 Q1	–	Sell	-11,030	Closed	-$325K	–	569
2024 Q4	$325K	Hold	11,030	–	–	0.01%	448
2024 Q3	$343K	Hold	11,030	–	–	0.01%	499
2024 Q2	$374K	Hold	11,030	–	–	0.02%	372
2024 Q1	$717K	Sell	11,030 -2,750	-20%	-$189K	0.04%	283
2023 Q4	$941K	Hold	13,780	–	–	0.06%	231
2023 Q3	$715K	Sell	13,780 -420	-3%	-$24.9K	0.05%	251
2023 Q2	$851K	Sell	14,200 -1,725	-11%	-$98.5K	0.06%	211
2023 Q1	$787K	Sell	15,925 -6,806	-30%	-$383K	0.06%	227
2022 Q4	$1.3M	Hold	22,731	–	–	0.13%	150
2022 Q3	$1.07M	Buy	+22,731	New	+$1.08M	0.11%	148

Other funds holding IMCR

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Robertson Stephens Wealth Management's IMCR Position: Q1 2026 in Review

Robertson Stephens Wealth Management sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 6,030 shares — an estimated $209K sold.

Robertson Stephens Wealth Management first reported a position in IMCR in Q3 2022 and held it in 12 quarters. The position peaked at $1.3M in Q4 2022. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Robertson Stephens Wealth Management reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
Robertson Stephens Wealth Management sold 6,030 Immunocore shares in Q1 2026, an estimated $209K.
Robertson Stephens Wealth Management first reported a position in Immunocore in Q3 2022 and held it in 12 quarters.
Robertson Stephens Wealth Management's Immunocore position peaked at $1.3M in Q4 2022.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.